BlueCrest Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-25,426
| Closed | -$35.3K | – | 147 |
|
|
2023
Q2 | $35.3K | Hold |
25,426
| – | – | ﹤0.01% | 120 |
|
|
2023
Q1 | $40.4K | Buy |
+25,426
| New | +$40.4K | ﹤0.01% | 222 |
|
|
2018
Q4 | – | Sell |
-6,942
| Closed | -$308K | – | 1020 |
|
|
2018
Q3 | $308K | Buy |
+6,942
| New | +$308K | 0.01% | 1008 |
|
|
2017
Q4 | – | Sell |
-5,099
| Closed | -$256K | – | 885 |
|
|
2017
Q3 | $256K | Buy |
+5,099
| New | +$256K | 0.01% | 658 |
|